Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial.

Cancer Res Treat · 2019 · PMC6473262 · PMID 30282452

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, high ERCC1 expression showed a trend of being associated with poor DFS, but it was not statistically significant on multivariate Cox analysis (HR, 2.08; 95% CI, 0.94 to 4.58; p=0.070).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.